Authors:
Oomen, SPMA
Lichtenauer-Kaligis, EGR
Verplanke, N
Hofland, J
Lamberts, SWJ
Lowenberg, B
Touw, IP
Citation: Spma. Oomen et al., Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2, LEUKEMIA, 15(4), 2001, pp. 621-627
Authors:
Ferone, D
Kwekkeboom, DJ
Pivonello, R
Bogers, ADJJ
Colao, A
Lamberts, SWJ
van Hagen, PM
Hofland, LJ
Citation: D. Ferone et al., In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features, J ENDOC INV, 24(7), 2001, pp. 522-528
Authors:
Muller, AF
Janssen, JAMJL
Lamberts, SWJ
Bidlingmaier, M
Strasburger, CJ
Hofland, L
van der Lely, AJ
Citation: Af. Muller et al., Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion, CLIN ENDOCR, 55(4), 2001, pp. 461-467
Authors:
Bruining, H
Bootsma, AH
Koper, JW
Bonjer, J
de Jong, FH
Lamberts, SWJ
Citation: H. Bruining et al., Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia, J CLIN END, 86(2), 2001, pp. 482-484
Authors:
van der Harst, E
de Herder, WW
Bruining, HA
Bonjer, HJ
de Krijger, RR
Lamberts, SWJ
van de Meiracker, AH
Boomsma, F
Stijnen, T
Krenning, EP
Bosman, FT
Kwekkeboom, DJ
Citation: E. Van Der Harst et al., [I-123]metaiodobenzylguanidine and [In-111]octreotide uptake in benign andmalignant pheochromocytomas, J CLIN END, 86(2), 2001, pp. 685-693
Authors:
Muller, AF
Leebeek, FWG
Janssen, JAMJL
Lamberts, SWJ
Hofland, L
Van Der Lely, AJ
Citation: Af. Muller et al., Acute effect of pegvisomant on cardiovascular risk markers in healthy men:Implications for the pathogenesis of atherosclerosis in GH deficiency, J CLIN END, 86(11), 2001, pp. 5165-5171
Authors:
Vaessen, N
Heutink, P
Janssen, JA
Witteman, JCM
Testers, L
Hofman, A
Lamberts, SWJ
Oostra, BA
Pols, HAP
van Duijn, CM
Citation: N. Vaessen et al., A polymorphism in the gene for IGF-I - Functional properties and risk for type 2 diabetes and myocardial infarction, DIABETES, 50(3), 2001, pp. 637-642
Citation: Swj. Lamberts, Hormone replacement therapy for somatopause: risk-benefit analysis and precedents in the treatment of menopause, GROWTH H I, 10, 2000, pp. S52-S53
Authors:
Nobels, FRE
de Herder, WW
van den Brink, WM
Kwekkeboom, DJ
Hofland, LJ
Zuyderwijk, J
de Jong, FH
Lamberts, SWJ
Citation: Fre. Nobels et al., Long-term treatment with the dopamine agonist quinagolide of patients withclinically non-functioning pituitary adenoma, EUR J ENDOC, 143(5), 2000, pp. 615-621
Authors:
Ferone, D
van Hagen, PM
Pivonello, R
Colao, A
Lamberts, SWJ
Hofland, LJ
Citation: D. Ferone et al., Physiological and pathophysiological role of somatostatin receptors in thehuman thymus, EUR J ENDOC, 143, 2000, pp. S27-S34
Authors:
Huizenga, NATM
De Herder, WW
Koper, JW
de Lange, P
van der Lely, AJ
Brinkmann, AO
de Jong, FH
Lamberts, SWJ
Citation: Natm. Huizenga et al., Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome, EUR J ENDOC, 142(5), 2000, pp. 472-476